ENTRY       D00606                      Drug
NAME        Guanfacine hydrochloride (JAN/USP);
            Intuniv (TN);
            Tenex (TN)
PRODUCT     INTUNIV (Takeda Pharmaceuticals America)
  GENERIC   GUANFACINE (A-S Medication Solutions)
            GUANFACINE (Actavis Pharma)
            GUANFACINE (Actavis Pharma)
            GUANFACINE (Ajanta Pharma USA)
            GUANFACINE (Alembic Pharmaceuticals Limited)
            GUANFACINE (Alembic Pharmaceuticals)
            GUANFACINE (Aurobindo Pharma Limited)
            GUANFACINE (AvKARE)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Bryant Ranch Prepack)
            GUANFACINE (Epic Pharma)
            GUANFACINE (Golden State Medical Supply)
            GUANFACINE (Major Pharmaceuticals)
            GUANFACINE (NORTHSTAR RXLLC)
            GUANFACINE (Proficient Rx LP)
            GUANFACINE (Proficient Rx LP)
            GUANFACINE (PuraCap Laboratories LLC dba Blu Pharmaceuticals)
            GUANFACINE (REMEDYREPACK)
            GUANFACINE (REMEDYREPACK)
            GUANFACINE (REMEDYREPACK)
            GUANFACINE (Slate Run Pharmaceuticals)
            GUANFACINE (Sun Pharmaceutical Industries)
            GUANFACINE (TWi Pharmaceuticals)
            GUANFACINE ER (Direct_Rx)
            GUANFACINE EXTENDED-RELEASE (A-S Medication Solutions)
            GUANFACINE EXTENDED-RELEASE (Apotex Corp.)
            GUANFACINE EXTENDED-RELEASE (Bryant Ranch Prepack)
            GUANFACINE EXTENDED-RELEASE (Bryant Ranch Prepack)
            GUANFACINE EXTENDED-RELEASE (Bryant Ranch Prepack)
            GUANFACINE EXTENDED-RELEASE (Bryant Ranch Prepack)
            GUANFACINE EXTENDED-RELEASE (Bryant Ranch Prepack)
            GUANFACINE HYDROCHLORIDE (A-S Medication Solutions)
            GUANFACINE HYDROCHLORIDE (American Health Packaging)
            GUANFACINE HYDROCHLORIDE (Amneal Pharmaceuticals LLC)
            GUANFACINE HYDROCHLORIDE (Amneal Pharmaceuticals of New York LLC)
            GUANFACINE HYDROCHLORIDE (AvKARE)
            GUANFACINE HYDROCHLORIDE (AvPAK)
            GUANFACINE HYDROCHLORIDE (Chartwell RX)
            GUANFACINE HYDROCHLORIDE (NuCare Pharmaceuticals)
            GUANFACINE HYDROCHLORIDE (Precision Dose)
            GUANFACINE HYDROCHLORIDE (REMEDYREPACK)
            GUANFACINE HYDROCHLORIDE (REMEDYREPACK)
            GUANFACINE HYDROCHLORIDE (TWi Pharmaceuticals)
            GUANFACINE HYDROCHLORIDE (Unichem Pharmaceuticals (USA))
FORMULA     C9H9Cl2N3O. HCl
EXACT_MASS  280.9889
MOL_WEIGHT  282.5542
CLASS       Cardiovascular agent
             DG01738  Centrally-acting antiadrenergic
             DG01456  Adrenergic receptor agonist
              DG01450  alpha-Adrenergic receptor agonist
               DG01449  alpha2-Adrenergic receptor agonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
             DG02925  CYP3A5 substrate
REMARK      Therapeutic category: 1179
            ATC code: C02AC02
            Chemical structure group: DG00250
            Product (DG00250): D00606<JP/US>
EFFICACY    Antihypertensive, alpha2-Adrenergic receptor agonist
  DISEASE   Attention deficit hyperactivity disorder [DS:H01895]
            Hypertension [DS:H01633]
COMMENT     Guanidine derivative
TARGET      ADRA2A [HSA:150] [KO:K04138]
  PATHWAY   hsa04022(150)  cGMP-PKG signaling pathway
            hsa04080(150)  Neuroactive ligand-receptor interaction
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
INTERACTION  
STR_MAP     map07215  alpha-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C02 ANTIHYPERTENSIVES
               C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
                C02AC Imidazoline receptor agonists
                 C02AC02 Guanfacine
                  D00606  Guanfacine hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Alpha-adrenergic Agonists
               Guanfacine
                D00606  Guanfacine hydrochloride (JAN/USP)
             Central Nervous System Agents
              Attention Deficit Hyperactivity Disorder Agents, Non-amphetamines
               Guanfacine
                D00606  Guanfacine hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              11  Agents affecting central nervous system
               117  Psychotropics
                1179  Others
                 D00606  Guanfacine hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01738  Centrally-acting antiadrenergic
               DG00250  Guanfacine
                D00606  Guanfacine hydrochloride
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00250  Guanfacine
                  D00606  Guanfacine hydrochloride
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00250  Guanfacine
                 D00606  Guanfacine hydrochloride
              DG02925  CYP3A5 substrate
               DG00250  Guanfacine
                D00606  Guanfacine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA2A
                 D00606  Guanfacine hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00606
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00606
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D00606
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01738  Centrally-acting antiadrenergic
               DG00250  Guanfacine
              DG01456  Adrenergic receptor agonist
               DG01450  alpha-Adrenergic receptor agonist
                DG01449  alpha2-Adrenergic receptor agonist
                 DG00250  Guanfacine
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00250  Guanfacine
              DG02925  CYP3A5 substrate
               DG00250  Guanfacine
DBLINKS     CAS: 29110-48-3
            PubChem: 7847672
            ChEBI: 5559
            LigandBox: D00606
            NIKKAJI: J262.680B
ATOM        16
            1   C8y C    24.2186  -16.1239
            2   C1b C    23.0015  -15.4193
            3   C8y C    24.2070  -17.5156
            4   C8y C    25.4239  -15.4134
            5   C5a C    21.7961  -16.1239
            6   C8x C    25.4239  -18.2144
            7   X   Cl   22.9956  -18.2087
            8   C8x C    26.6353  -16.1122
            9   X   Cl   25.4182  -14.0101
            10  N1b N    20.5848  -15.4193
            11  O5a O    21.7961  -17.5215
            12  C8x C    26.6353  -17.5156
            13  C2c C    19.3677  -16.1239
            14  N1a N    18.1565  -15.4193
            15  N2a N    19.3677  -17.5215
            16  X   Cl   29.0752  -16.4966
BOND        15
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12   10  13 1
            13   13  14 1
            14   13  15 2
            15    8  12 1
///
